Bank Of New York Mellon Corp Lantern Pharma Inc. Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.19 - $6.04 $110,951 - $159,939	26,480 New	26,480 $159,000
Q2 2022 Aug 15, 2022	SELL	$4.82 - $7.45 $1,373 - $2,123	-285 Reduced 1.06%	26,480 $151,000
Q2 2021 Aug 11, 2021	BUY	$12.94 - $19.89 $193,970 - $298,151	14,990 Added 127.3%	26,765 $0
Q1 2021 May 13, 2021	BUY	$14.34 - $21.92 $168,853 - $258,108	11,775 New	11,775 $0

1.31M

39.8K

6.1K

Ticker LTRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 10,830,900
Market Cap $37M
Description
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.